|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0518 DKK | -5.47% |
|
-15.36% | +72.67% |
| 03-29 | Dancann Pharma Plans Up to DKK19 Million Rights Issue | MT |
| 02-28 | DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge | MT |
Dancann Pharma A/S announced that the Company appoints Martin Vedel Ernst as new Chief Financial Officer. In the future, DanCann Pharma's financial tasks will be handled by Martin Vedel Ernst. Martin Ernst has an educational background as Cand.
Merc. Aud. from Copenhagen Business School and business experience from jobs as accountant at Deloitte and as Group Financial Controller at Vestas.
| 1st Jan change | Capi. | |
|---|---|---|
| +72.67% | 1.33M | |
| +9.83% | 118B | |
| +10.80% | 106B | |
| -10.84% | 23.4B | |
| -1.69% | 22.1B | |
| -10.23% | 18.34B | |
| -41.92% | 16.59B | |
| -15.11% | 15.97B | |
| +6.62% | 14.03B | |
| +17.53% | 11.67B |
DANCANN PHARMA A/S 
